"The survival advantage of pancreas after kidney transplant"

Recorded live on Monday, May 4th, 2020 • Hosted by the Kidney Pancreas Community of Practice (KPCOP)

"The survival advantage of pancreas after kidney transplant."
(Am J Transplant. 2019 Mar;19(3):823-830. doi: 10.1111/ajt.15106. Epub 2018 Oct 4.)

In this article:
"Patient survival after pancreas after kidney transplant (PAK) has been reported to be inferior to patient survival after simultaneous pancreas-kidney transplant (SPK). The authors examine national data to further explore allograft (kidney and pancreas) and patient survival after PAK... [The authors found that] successful PAK offers a survival advantage compared with receiving neither a kidney nor a pancreas transplant. These data also suggest that receiving a pancreas (after kidney) transplant may have a protective effect on the kidney allograft."

Speaker:
Jonathan Fridell, MD • Indiana University School of Medicine, Indianapolis, IN

Moderator:
Jon Odorico, MD • University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI

Live webinars in the AST/AJT Journal Club series are open to both members and non-members. Pre-registration is required.

Watch Video

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.